Free tool
Rare disease stocks
We cover 1 company grouped under the Rare disease theme. The median market value in the group is $61.56M. Across the group, the median move over the past trading day is +0.14%. Price change over the past year runs from +44.6% to +44.6% across the middle 80 percent of the group, with a median of +44.6%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
1 company of 268 matches these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0IIM.L | Esperion Therapeutics, Inc. | $61.56M | Micro cap | +44.65% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.